Cambridge Investment Research Advisors’s Capital Group Core Balanced ETF CGBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.5M Buy
2,594,048
+298,834
+13% +$11M 0.22% 81
2026
Q1
$79M Buy
2,295,214
+43,205
+2% +$1.55M 0.2% 92
2025
Q4
$79.6M Buy
2,252,009
+330,471
+17% +$11.6M 0.21% 83
2025
Q3
$66.7M Buy
1,921,538
+285,476
+17% +$9.73M 0.18% 102
2025
Q2
$54.7M Buy
1,636,062
+87,102
+6% +$2.75M 0.17% 111
2025
Q1
$48M Buy
1,548,960
+277,492
+22% +$8.81M 0.16% 118
2024
Q4
$39.8M Buy
1,271,468
+317,316
+33% +$10M 0.13% 147
2024
Q3
$29.6M Buy
954,152
+275,020
+40% +$8.33M 0.1% 197
2024
Q2
$20.2M Buy
679,132
+185,251
+38% +$5.38M 0.07% 261
2024
Q1
$14.4M Buy
493,881
+269,552
+120% +$7.57M 0.06% 342
2023
Q4
$6.13M Buy
+224,329
New +$5.77M 0.03% 607

Other funds holding CGBL

Cambridge Investment Research Advisors's CGBL Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Capital Group Core Balanced ETF (CGBL) stake by 13% in Q2 2026, buying an estimated $11M and bringing the position to 2,594,048 shares worth $98.5M. The position accounts for 0.22% of the portfolio, ranked #81.

Cambridge Investment Research Advisors first reported a position in CGBL in Q4 2023 and has held it in 11 quarters since. 193 funds tracked by Wall St. Rank hold CGBL as of Q2 2026.

  • Cambridge Investment Research Advisors held 2,594,048 shares of Capital Group Core Balanced ETF worth $98.5M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 298,834 Capital Group Core Balanced ETF shares in Q2 2026, an estimated $11M.
  • Capital Group Core Balanced ETF made up 0.22% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #81 holding.
  • Cambridge Investment Research Advisors first reported a position in Capital Group Core Balanced ETF in Q4 2023 and has held it in 11 quarters since.
  • 193 funds tracked by Wall St. Rank held Capital Group Core Balanced ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.